LambdaGen Pte. Ltd.

LambdaGen Therapeutics envisions development of next-generation personalized stem-cell based therapeutics using its proprietary non-viral genome insertion system based on λ-integrase system. Our versatile platform allows insertion of large fragments of DNA at specific site in the human genome which empowers us to propel our R&D efforts to develop innovative therapeutic solutions for a spectrum of genetic diseases and cancer immunotherapy.